<DOC>
	<DOCNO>NCT01136135</DOCNO>
	<brief_summary>To find non-invasive alternative ( use cardiac MRI ) invasive endomyocardial biopsy serial detection ( EMB ) follow-up cellular rejection heart transplant childhood .</brief_summary>
	<brief_title>Cardiac Magnetic Resonance Imaging ( CMRI ) Detection Cardiac Transplant Rejection</brief_title>
	<detailed_description>Objectives To find non-invasive alternative ( use cardiac MRI ) invasive endomyocardial biopsy serial detection follow-up cellular rejection heart transplant childhood . Background Detection cardiac rejection major problem cardiac transplantation . Invasive screening predefined time interval cellular rejection use endomyocardial biopsy standard procedure . However , cardiac biopsy distress risky also costly . Moreover , histological expression allograft rejection patchy , endomyocardial biopsy may lead sample error . Thus , sensitivity low variable ( range 40 95 % ) , indication biopsy still debate . Materials method All patient undergone cardiac transplant potentially eligible . They prospectively include study . They examinations , routine endomyocardial biopsy cardiac MRI . Histological diagnosis cellular rejection give BILLINGHAM classification use daily practice . Diagnosis rejection cardiac MRI define association hyperintensity T2-weighted sequence , gadolinium-enhanced sequence include SSFP ( study state free precession ) myocardial delay enhancement . Both MRI parameter attest presence myocardial oedema relate acute rejection . Myocardial oedema also associate segmental abnormality myocardial contraction assess CMR-tagged sequence . Written informed consent require patient . Institutional review board approval also require . Expected result clinical implication We expect demonstrate CMRI effective detection cellular rejection high sensitivity ( expect sensitivity &gt; 95 % ) compare cardiac biopsy . In condition , cardiac MRI could replace invasive biopsy serial detection follow-up rejection heart transplant .</detailed_description>
	<criteria>patient undergone cardiac transplant eligible consent allergy contrast agent ( Gadolinium ) severe renal failure ( clearance &lt; 30ml/min/1.73mÂ² ) claustrophobia severe arrhythmia absence medical care insurance pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Heart transplant rejection</keyword>
	<keyword>cardiac MRI</keyword>
	<keyword>diagnosis</keyword>
</DOC>